ClinicaliQ Trial Snapshot
- Adiposity and Iron Requirements in Pregnancy — Recruiting • Non-phase study • Gastroenterology • NCT06425796.
- What is being tested: A double-blind randomized controlled trial investigating whether body fat (adiposity) affects how pregnant women respond to different daily iron supplementation doses (25 mg versus 50 mg), with 312 pregnant women from antenatal clinics.
- Patient eligibility overview: Pregnant women recruited from antenatal clinics are eligible; the study stratifies participants by adiposity level to examine differential responses to iron supplementation across different body compositions.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This study aims to explore how body fat influences the response to either 25 or 50 mg of daily iron supplements during pregnancy. We will conduct a double-blind randomized controlled intervention study involving 312 pregnant women recruited from antenatal clinics in the Northern Trust Area. Participants will be randomly assigned to receive either 25 or 50 mg of iron per day from 12 weeks of pregnancy until delivery, using the Active Iron supplement brand. Blood samples will be collected at 12, 28 and 36 weeks gestation and umbilical cord blood…
Eligibility Snapshot
- :- Pregnant women * Age ≥ 18 years * BMI ≥18.5 kg/m2 * Without current pregnancy complications (for example, severe bleeding, Diabetes Mellitus, hyperemesis gravidarum, ectopic and molar pregnancies) * At least 12 Gestational Week * Singleton pregnancy confirmed with the first ultrasound scan * Participants who are currently taking multivitamins will be included. They will be asked to discontinue any current supplementation.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.